Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-031792
Filing Date
2024-08-14
Accepted
2024-08-14 06:14:54
Documents
42
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 570201
2 ex31-1.htm EX-31.1 8279
3 ex31-2.htm EX-31.2 8200
4 ex32-1.htm EX-32.1 4962
5 ex32-2.htm EX-32.2 4898
  Complete submission text file 0001493152-24-031792.txt   3007835

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ladx-20240630.xsd EX-101.SCH 21830
7 XBRL CALCULATION FILE ladx-20240630_cal.xml EX-101.CAL 28288
8 XBRL DEFINITION FILE ladx-20240630_def.xml EX-101.DEF 104168
9 XBRL LABEL FILE ladx-20240630_lab.xml EX-101.LAB 217733
10 XBRL PRESENTATION FILE ladx-20240630_pre.xml EX-101.PRE 166632
44 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 372342
Mailing Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049
Business Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049 310-826-5648
LadRx Corp (Filer) CIK: 0000799698 (see all company filings)

EIN.: 581642750 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15327 | Film No.: 241203958
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)